Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Lineage, Inc. (LINE)

Lineage appoints Paul Beiboer to board; director James Wyper resigns

Neutral Impact 2 of 5 leadership Written later

Lineage, Inc. named Paul Beiboer as a director on September 23, 2026, filling the seat vacated by James Wyper's resignation on September 22, 2026. The filing also says Chief Transformation Officer Sudarsan Thattai will stop serving as an executive officer on September 28, 2026, and will remain with the company as an adviser until his planned retirement on April 2, 2027.

Key points

  • James Wyper resigned as a director effective immediately, notified September 22, 2026; the company says it was not due to any disagreement with the company.
  • Paul Beiboer was appointed to the Board on September 23, 2026, serving until the 2027 annual meeting and joining the Talent and Compensation Committee.
  • Sudarsan Thattai's Chief Transformation Officer duties move to other management on September 28, 2026; he continues as Special Adviser under a Transition Agreement with substantially the same compensation through April 2, 2027.

The filing

CompanyLineage, Inc. (LINE)
Form8-K, current report
Filed with the SECSep 24, 2026, 4:21 PM ET
Accession number0001868159-26-000044

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 24, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.